A GROUNDBREAKING genetic treatment with the potential to cure sickle cell disease will be rolled out ... The treatment uses cutting-edge Crispr gene editing to remove blood from the patient ...

uses a Nobel Prize-winning gene-editing technology called Crispr. Some 1,700 patients with sickle cell disease could be eligible for the one-time treatment, which clinical trials have suggested ...

LONDON — People in England with sickle cell disease will now be able to access the world’s first CRISPR-based medicine under a pricing and reimbursement agreement reached between U.K. health ...

treatment to be used to treat those with severe sickle cell disease in England. Exa-cel (sometimes called CRISPR) is stem cell treatment that doesn’t require a sibling donor match. And the new ...

A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease ... to be licensed using gene-editing tool Crispr, which earned its inventors the ...

The CRISPR-based gene therapy Casgevy (exagamglogene autotemcel) has been made available to patients with sickle cell disease in England, following positive guidance issued by the National ...

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy ...

for the treatment of severe sickle cell disease, a life-limiting blood disorder, in older children and adults. The one-time therapy uses clustered regularly interspaced short palindromic repeat ...

Some with severe sickle cell disease in England will now be able to access landmark CRISPR gene editing therapy, according to new health guidelines which were hailed as marking a “significant shift” ...